Comparison of the effect of consuming olive oil and sunflower oil on blood glucose and lipid profile in type 2 diabetic female patients

Comparison of the effect of consuming olive oil and sunflower oil as the substitute for a portion of daily dietary fat on fasting and postprandial blood glucose and lipid profile in type 2 diabetic female patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT138808202697N1

Enrollment

Registered

2010-01-05

Start date

2009-12-07

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus. Non-insulin-dependent diabetes mellitus

Interventions

Intervention 1: Olive oil - 40% of total dietary fat intake - for 3 weeks. Intervention 2: Sunflower oil - 40% of total dietary fat intake - for 3 weeks.

Treatment - Other

Olive oil - 40% of total dietary fat intake - for 3 weeks

Sunflower oil - 40% of total dietary fat intake - for 3 weeks

Eligibility

Sex/Gender

Female

Age

No minimum to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria -Type II diabetes (FBS>126mg/dl) -Menopause women. Less than 60 years old -Not taking insulin and any drug that affects lipids metabolism (lipid-lowering drugs, multivitamins, hormones and beta-blockers) -No heart, liver, kidney diseases, no hypothyroidism or hyperthyroidism -Consumption of hydrogenated vegetable oil and no consumption of olive oil, sunflower oil and corn oil during the three weeks before starting the study -No abusing of smoke, alcohol or drugs Exclusion criteria -Not following the recommended diet changes -More or less than 5 percent changes in the body weight during one month -Occurrence of gastrointestinal, liver or ischemic heart diseases -Any changes in taking medicines or starting to take insulin -Taking any drug that affects lipids metabolism (lipid-lowering drugs, multivitamins, hormones and beta-blockers) during study -Changes in physical activity

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Fasting Blood Sugar (FBS). Timepoint: At the beginning of the study, and at the end of the weeks 3, 6, and 9. Method of measurement: FBS, PPBS measurment.	—

Secondary

Measure	Time frame
Blood Lipids. Timepoint: At the beginning of the study, and at the end of the weeks 3, 6, and 9. Method of measurement: Fasting and Postprandial Blood Triglyceride, Total Cholesterol , LDL-C, HDL-C, TC/HDLC, LDL-C/HDL-C, TG/HDL-C levels measurement.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSaloomeh Armin

Shaheed Beheshti University of Medical Sciences - Faculty of Nutrition Sciences and Food Technology

s.armin@nnftri.ac.ir+98 21 2236 0658

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026